Literature DB >> 3219551

Central and peripheral release of vasopressin and oxytocin in the conscious rat after osmotic stimulation.

R Landgraf1, I Neumann, H Schwarzberg.   

Abstract

Vasopressin (AVP) and oxytocin (OXT) were measured by radioimmunoassay in push-pull perfusates and tissue samples of various brain areas, plasma and cerebrospinal fluid (CSF) of male rats in response to osmotic stimulation. Hypertonic saline caused a significant rise in plasma AVP and OXT and different changes in peptide contents, in the septum and hippocampus at 30 and 60 min after intraperitoneal injection. Push-pull perfusion (20 microliters artificial CSF/min, 30-min periods) of the septum and dorsal hippocampus of conscious, unrestrained animals revealed a significant, stimulus-evoked release of both AVP and OXT. This release was: (1) not always reflected by corresponding changes in the regional peptide content; (2) simultaneous with the peripheral release from the posterior pituitary; and (3) probably the result of synaptic/parasynaptic events as suggested by use of agents in the artificial CSF which either inhibit or facilitate the release from intact fibre terminals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219551     DOI: 10.1016/0006-8993(88)90689-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Central peptidergic neurons are hyperactive during collateral sprouting and inhibition of activity suppresses sprouting.

Authors:  J A Watt; C W Moffet; X Zhou; S Short; J P Herman; C M Paden
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

2.  A spinal vasopressinergic mechanism mediates hyperosmolality-induced sympathoexcitation.

Authors:  V R Antunes; S T Yao; A E Pickering; D Murphy; J F R Paton
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

3.  Perinatal exposure to octabromodiphenyl ether mixture, DE-79, alters the vasopressinergic system in adult rats.

Authors:  Mhar Y Alvarez-Gonzalez; Eduardo Sánchez-Islas; Samuel Mucio-Ramirez; Patricia de Gortari; María I Amaya; Prasada Rao S Kodavanti; Martha León-Olea
Journal:  Toxicol Appl Pharmacol       Date:  2020-02-04       Impact factor: 4.219

4.  Thermoadaptive influence on reactivity pattern of vasopressinergic neurons in the guinea pig.

Authors:  G Merker; J Roth; E Zeisberger
Journal:  Experientia       Date:  1989-08-15

5.  Role of septal vasopressin innervation in paternal behavior in prairie voles (Microtus ochrogaster).

Authors:  Z Wang; C F Ferris; G J De Vries
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

6.  Central oxytocin inhibition of salt appetite in rats: evidence for differential sensing of plasma sodium and osmolality.

Authors:  R E Blackburn; W K Samson; R J Fulton; E M Stricker; J G Verbalis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Vasopressin indirectly excites dorsal raphe serotonin neurons through activation of the vasopressin1A receptor.

Authors:  B D Rood; S G Beck
Journal:  Neuroscience       Date:  2013-12-15       Impact factor: 3.590

8.  Aging-related impairment of urine-concentrating mechanisms correlates with dysregulation of adrenocortical angiotensin type 1 receptors in male Fischer rats.

Authors:  Hong Ji; Wei Zheng; Xie Wu; Robert C Speth; Joseph G Verbalis; Lauren M Stein; Gina L C Yosten; Willis K Samson; Kathryn Sandberg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-23       Impact factor: 3.619

Review 9.  Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery.

Authors:  Zhimin Song; H Elliott Albers
Journal:  Front Neuroendocrinol       Date:  2017-10-18       Impact factor: 8.606

Review 10.  Endogenous modulators of synaptic transmission: cannabinoid regulation in the supraoptic nucleus.

Authors:  Neil A McDonald; J Brent Kuzmiski; Nima Naderi; Yannick Schwab; Quentin J Pittman
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.